Results 11 to 20 of about 89,882 (308)

Neurotensin receptors in pancreatic ductal carcinomas [PDF]

EJNMMI Research, 2015
Abstract Background The frequent expression of neurotensin receptors (NT-R) in primaries of pancreatic ductal carcinomas has triggered the development of radioactive neurotensin analogs for possible in vivo targeting of these tumors.
Körner Jachertz, Meike, Waser, Beatrice, Strobel, Oliver, Büchler, Markus, Reubi, Jean Claude   +4 more
openaire   +3 more sources

Role of Fibroblast Growth Factor Receptor 2 in Pancreatic Cancer: Potential Target for New Therapeutic Approach? [PDF]

, 2015
Fibroblast growth factors and their receptors play a key role in cell proliferation, migration and differentiation. Fibroblast growth factor receptor 2 (FGFR2) is involved in carcinogenesis and its altered expression has been shown in several tumors ...
Angeloni, Antonio, Ceccarelli, Simona, Vescarelli, Enrica   +2 more
core   +1 more source

Repeated Pancreatectomy for Recurrent Pancreatic Carcinoma after Pylorus-Preserving Pancreatoduodenectomy: Report of Two Patients

Case Reports in Gastroenterology, 2010
Repeated pancreatectomy for pancreatic carcinoma is extremely rare. We report two such patients who underwent pancreatectomy for carcinoma developing in the pancreatic remnant after pylorus-preserving pancreatoduodenectomy (PpPD) for invasive pancreatic ...
Toshitatsu Ogino, Junji Ueda, Norihiro Sato, Shunichi Takahata, Kazuhiro Mizumoto, Masafumi Nakamura, Yoshinao Oda, Masao Tanaka   +7 more
doaj   +1 more source

MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater’s papilla adenocarcinoma [PDF]

, 2017
iRNA expression abnormalities in adenocarcinoma arising from pancreatic ductal system (PDAC) and Vater’s papilla (PVAC) could be associated with distinctive pathologic features and clinical cancer behaviours.
Andriulli, Angelo, Biagini, Tommaso, Capocefalo, Daniele, Carella, Massimo, Copetti, Massimiliano, De Bonis, Antonio, Di Sebastiano, Pierluigi, Francesco Di Mola, Fabio, Fusilli, Caterina, Maiello, Evaristo, Mastrodonato, Nicola, Mazza, Tommaso, Pazienza, Valerio, Piepoli, Ada, Tavano, Francesca   +14 more
core   +1 more source

Multidisciplinary Approach to a Patient with Acinar Cell Carcinoma, a Rare Pancreatic Malignancy

healthbook TIMES. Oncology Hematology, 2021
Acinar cell carcinoma (ACC) of the pancreas is a relatively rare malignant neoplasm that constitutes about 1% of all pancreatic exocrine tumors. The disease is generally managed similarly as pancreatic ductal adenocarcinoma (PDAC), with surgical ...
Maria Celeste Palmarocchi, Elisabetta Merlo, Marco Cefali, Sara De Dosso   +3 more
doaj   +2 more sources

An indolent pancreatic ductal adenocarcinoma with psammoma bodies and a coincidental neuroendocrine tumor

Human Pathology: Case Reports, 2019
Pancreatic ductal adenocarcinoma is a very aggressive neoplasm with a low survival rate, comprising the majority of pancreatic malignancies. Psammoma bodies have rarely been reported in pancreatic ductal adenocarcinoma, and their clinicopathologic ...
Hongxing Gui, Christopher P. Julien, Suehyb G. Alkhatib, Michael A. Husson   +3 more
doaj   +1 more source

Diabetic ketoacidosis as the presenting manifestation of pancreatic adenocarcinoma with cystic features

Turkish Journal of Emergency Medicine, 2017
The common presenting symptoms of pancreatic cancer are abdominal pain, weight loss, and jaundice. Pancreatic adenocarcinoma presenting with diabetic ketoacidosis is a very rare emergent clinical condition.
Tezcan Kaya, Sumeyye Korkmaz, Erdem Vargol, Alper Karacan, Hakan Cinemre   +4 more
doaj   +1 more source

Colloid Carcinoma of the Pancreas with a Series of Radiological and Pathological Studies for Diagnosis: A Case Report

Diagnostics, 2022
Pancreatic colloid carcinoma is an uncommon and unique malignancy possessing a significantly more favorable prognosis than that of ordinary pancreatic ductal adenocarcinoma. Accurate diagnosis of this rare entity is thus important for leading the ensuing
Chuan-Han Chen, Hong-Zen Yeh, Hsin-Ni Li
doaj   +1 more source

Clinical and molecular characterization of HER2 amplified-pancreatic cancer [PDF]

, 2013
<p>Background: Pancreatic cancer is one of the most lethal and molecularly diverse malignancies. Repurposing of therapeutics that target specific molecular mechanisms in different disease types offers potential for rapid improvements in outcome ...
Biankin, A.V., Chang, D.K., Chantrill, L., Chin, V., Chou, A., Cowley, M.J., Gill, A.J., Goldstein, D., Grimmond, S.M., Humphris, J., Johns, A.L., Kassahn, K.S., Mead, R., Miller, D.K., Morey, A.L., Musgrove, E.A., Nagrial, A.M., Nones, K., Pajic, M., Patch, A.M., Pearson, J.V., Pinese, M., Rooman, I., Samra, J.S., Toon, C.W., Waddell, N., Wasan, H., Wu, J.   +27 more
core   +3 more sources

Ca2+ Signaling and Its Potential Targeting in Pancreatic Ductal Carcinoma [PDF]

Cancers, 2021
Pancreatic cancer (PC) is a major cause of cancer-associated mortality in Western countries (and estimated to be the second cause of cancer deaths by 2030). The main form of PC is pancreatic adenocarcinoma, which is the fourth most common cause of cancer-related death, and this situation has remained virtually unchanged for several decades.
Bettaieb, Louay, Brulé, Maxime, Chomy, Axel, Diedro, Mel, Fruit, Malory, Happernegg, Eloise, Heni, Leila, Horochowska, Anaïs, Housseini, Mahya, Klouyovo, Kekely, Laratte, Agathe, Leroy, Alice, Lewandowski, Paul, Louvieaux, Joséphine, Moitié, Amélie, Tellier, Rémi, Titah, Sofia, Vanauberg, Dimitri, Woesteland, Flavie, Prevarskaya, Natalia, Lehen’kyi, V’yacheslav   +20 more
openaire   +2 more sources